| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 25, 2003
From the Heart Institute (InCor) (J.J.G.D., M.L.C.V., E.M.K., J.A.F.R.) and Renal Transplant Unit (E.S., F.J.deP., L.E.I.), Hospital das Clínicas, University of São Paulo Medical School, Brazil. * To whom correspondence should be addressed. E-mail: hipjayme{at}incor.usp.br.
Abstract--Guidelines for the detection of coronary artery disease (CAD) and assess of risk in renal transplant candidates are based on the results of noninvasive testing, according to data originated in the nonuremic population. We evaluated prospectively the accuracy of 2 noninvasive tests and risk stratification in detecting CAD (
Revised on April 1, 2003
Coronary Angiography Is the Best Predictor of Events in Renal Transplant Candidates Compared With Noninvasive Testing
Jose Jayme G. De Lima*;
70% obstruction) and assessing cardiac risk by using coronary angiography (CA). One hundred twenty-six renal transplant candidates who were classified as at moderate (
50 years) or high (diabetes, extracardiac atherosclerosis, or clinical coronary artery disease) coronary risk underwent myocardial scintigraphy (SPECT), dobutamine stress echocardiography, and CA and were followed for 6 to 48 months. The prevalence of CAD was 42%. The sensitivities and negative predictive values for the 2 noninvasive tests and risk stratification were <75%. After 6 to 48 months, there were 18 cardiac events, 9 fatal. Risk stratification (P=0.007) and CA (P=0.0002) predicted the crude probability of surviving free of cardiac events. The probability of event-free survival at 6, 12, 24, 36, and 48 months were 98%, 98%, 94%, 94%, and 94% in patients with <70% stenosis on CA and 97%, 87%, 61%, 56%, and 54% in patients with
70% stenosis. Multivariate analysis showed that the sole predictor of cardiac events was critical coronary lesions (P=0.003). Coronary angiography may still be necessary for detecting CAD and determining cardiac risk in renal transplant candidates. The data suggest that current algorithms based on noninvasive testing in this population should be revised.
This article has been cited by other articles:
![]() |
D. K. Hothi, L. Rees, J. Marek, J. Burton, and C. W. McIntyre Pediatric Myocardial Stunning Underscores the Cardiac Toxicity of Conventional Hemodialysis Treatments Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 790 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gang, M. Dabhi, and M. M. Rajapurkar Ischaemia imaging in type 2 diabetic kidney transplant candidates is coronary angiography essential? Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2334 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. W. Gowdak, F. J. de Paula, L. A. M. Cesar, E. E. M. Filho, L. E. Ianhez, E. M. Krieger, J. A. F. Ramires, and J. J. G. De Lima Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1456 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.H.H. Feringa, J.J. Bax, O. Schouten, and D. Poldermans Ischemic heart disease in renal transplant candidates: Towards non-invasive approaches for preoperative risk stratification Eur J Echocardiogr, October 1, 2005; 6(5): 313 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fishbane Cardiovascular Risk Evaluation before Kidney Transplantation J. Am. Soc. Nephrol., April 1, 2005; 16(4): 843 - 845. [Full Text] [PDF] |
||||
![]() |
C. A. Herzog, J. J. G. De Lima, E. Sabbaga, M. L. C. Vieira, F. J. de Paula, L. E. Ianhez, E. M. Krieger, and J. A. Ramires Stress Imaging in Renal Transplant Candidates * Response Hypertension, April 1, 2004; 43(4): e20 - e21. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |